ST-Segment Elevation Acute Myocardial Infarction Complicated by Cardiogenic Shock: Early Predictors of Very Long-Term Mortality.

ST-elevation myocardial infarction cardiogenic shock long-term mortality primary percutaneous coronary intervention risk score

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
21 May 2021
Historique:
received: 02 04 2021
revised: 07 05 2021
accepted: 20 05 2021
entrez: 2 6 2021
pubmed: 3 6 2021
medline: 3 6 2021
Statut: epublish

Résumé

Cardiogenic shock (CS) is the leading cause of in-hospital mortality in ST-segment elevation myocardial infarction (STEMI). Only limited data are available on the long-term outcome of STEMI patients with CS undergoing contemporary treatment. We aimed to investigate long-term mortality and its predictors in STEMI patients with CS and to develop a risk score for long-term mortality prediction. We retrospectively included 465 patients with STEMI complicated by CS and treated with primary angioplasty and intra-aortic balloon pump between 2005 and 2018. Long-term mortality, including both in-hospital mortality and all-cause mortality following discharge from the index hospitalization, was the primary endpoint. The long-term mortality (median follow-up 4 (2.0-5.2) years) was 60%, including in-hospital mortality (34%). At multivariate analysis, independent predictors of long-term mortality were age (HR 1.41, each 10-year increase), admission left ventricular ejection fraction (HR 1.51, each 10%-unit decrease) and creatinine (HR 1.28, each mg/dl increase), and acute kidney injury (HR 1.81). When these predictors were pooled together, the area under the curve (AUC) for long-term mortality was 0.80 (95% CI 0.75-0.84). Using the four variables, we developed a risk score with a mean (cross-validation analysis) AUC of 0.79. When the score was applied to in-hospital mortality, its AUC was 0.79, and 0.76 when the score was applied to all-cause mortality following discharge. In STEMI patients with CS, the risk of death is still substantial in the years following the index event. A simple clinical score at the time of the index event accurately predicts long-term mortality risk.

Sections du résumé

BACKGROUND BACKGROUND
Cardiogenic shock (CS) is the leading cause of in-hospital mortality in ST-segment elevation myocardial infarction (STEMI). Only limited data are available on the long-term outcome of STEMI patients with CS undergoing contemporary treatment. We aimed to investigate long-term mortality and its predictors in STEMI patients with CS and to develop a risk score for long-term mortality prediction.
METHODS AND RESULTS RESULTS
We retrospectively included 465 patients with STEMI complicated by CS and treated with primary angioplasty and intra-aortic balloon pump between 2005 and 2018. Long-term mortality, including both in-hospital mortality and all-cause mortality following discharge from the index hospitalization, was the primary endpoint. The long-term mortality (median follow-up 4 (2.0-5.2) years) was 60%, including in-hospital mortality (34%). At multivariate analysis, independent predictors of long-term mortality were age (HR 1.41, each 10-year increase), admission left ventricular ejection fraction (HR 1.51, each 10%-unit decrease) and creatinine (HR 1.28, each mg/dl increase), and acute kidney injury (HR 1.81). When these predictors were pooled together, the area under the curve (AUC) for long-term mortality was 0.80 (95% CI 0.75-0.84). Using the four variables, we developed a risk score with a mean (cross-validation analysis) AUC of 0.79. When the score was applied to in-hospital mortality, its AUC was 0.79, and 0.76 when the score was applied to all-cause mortality following discharge.
CONCLUSIONS CONCLUSIONS
In STEMI patients with CS, the risk of death is still substantial in the years following the index event. A simple clinical score at the time of the index event accurately predicts long-term mortality risk.

Identifiants

pubmed: 34064067
pii: jcm10112237
doi: 10.3390/jcm10112237
pmc: PMC8196779
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Heart. 2005 Mar;91(3):339-44
pubmed: 15710715
Crit Care Med. 2010 Feb;38(2):438-44
pubmed: 19789449
Circulation. 2016 Mar 15;133(11):1135-47
pubmed: 26490017
Eur Heart J Acute Cardiovasc Care. 2019 Dec;8(8):727-737
pubmed: 28777005
Eur Heart J Acute Cardiovasc Care. 2018 Dec;7(8):743-754
pubmed: 27708109
Circulation. 2018 Nov 11;:
pubmed: 30586721
Ann Intern Med. 2009 Feb 3;150(3):170-7
pubmed: 19189906
JACC Heart Fail. 2015 Mar;3(3):234-42
pubmed: 25742760
Clin Cardiol. 2019 Jan;42(1):111-119
pubmed: 30443916
Eur Heart J. 2018 Jan 7;39(2):119-177
pubmed: 28886621
Open Heart. 2016 Apr 15;3(1):e000405
pubmed: 27099764
J Clin Med. 2020 Jul 27;9(8):
pubmed: 32727034
N Engl J Med. 1999 Aug 26;341(9):625-34
pubmed: 10460813
JAMA. 2006 Jun 7;295(21):2511-5
pubmed: 16757723
J Am Coll Cardiol. 2017 Apr 18;69(15):1913-1920
pubmed: 28408020
Catheter Cardiovasc Interv. 2011 Oct 1;78(4):505-11
pubmed: 21953748
Cardiovasc Interv Ther. 2018 Oct;33(4):338-344
pubmed: 28918455
Clin Cardiol. 2019 Apr;42(4):484-493
pubmed: 30815887
Eur Heart J. 2012 Oct;33(20):2535-43
pubmed: 22927559
Crit Care Clin. 2014 Jul;30(3):391-412
pubmed: 24996603
Circulation. 2009 Mar 10;119(9):1211-9
pubmed: 19237658
Eur Heart J Acute Cardiovasc Care. 2015 Jun;4(3):270-7
pubmed: 25425723
J Am Heart Assoc. 2016 Jul 06;5(7):
pubmed: 27385429
Am Heart J. 2009 Oct;158(4):680-7
pubmed: 19781431
N Engl J Med. 1999 Apr 15;340(15):1162-8
pubmed: 10202167
BMC Res Notes. 2018 Oct 11;11(1):721
pubmed: 30309379
Clin Cardiol. 2016 Nov;39(11):665-669
pubmed: 27775864
JACC Heart Fail. 2013 Jun;1(3):223-9
pubmed: 24621874
Arch Cardiovasc Dis. 2018 Oct;111(10):555-563
pubmed: 29478810
J Am Heart Assoc. 2014 Jan 13;3(1):e000590
pubmed: 24419737

Auteurs

Nicola Cosentino (N)

Centro Cardiologico Monzino IRCCS, 20138 Milan, Italy.

Marta L Resta (ML)

Centro Cardiologico Monzino IRCCS, 20138 Milan, Italy.

Alberto Somaschini (A)

Coronary Care Unit and Laboratory of Clinical and Experimental Cardiology-Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy.
Unit of Cardiology, Department of Molecular Medicine, Università degli studi di Pavia, 271000 Pavia, Italy.

Jeness Campodonico (J)

Centro Cardiologico Monzino IRCCS, 20138 Milan, Italy.

Giampaolo D'Aleo (G)

Centro Cardiologico Monzino IRCCS, 20138 Milan, Italy.

Giovanni Di Stefano (G)

Centro Cardiologico Monzino IRCCS, 20138 Milan, Italy.

Claudia Lucci (C)

Centro Cardiologico Monzino IRCCS, 20138 Milan, Italy.

Marco Moltrasio (M)

Centro Cardiologico Monzino IRCCS, 20138 Milan, Italy.

Alice Bonomi (A)

Centro Cardiologico Monzino IRCCS, 20138 Milan, Italy.

Stefano Cornara (S)

Coronary Care Unit and Laboratory of Clinical and Experimental Cardiology-Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy.
Unit of Cardiology, Department of Molecular Medicine, Università degli studi di Pavia, 271000 Pavia, Italy.

Andrea Demarchi (A)

Coronary Care Unit and Laboratory of Clinical and Experimental Cardiology-Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy.
Unit of Cardiology, Department of Molecular Medicine, Università degli studi di Pavia, 271000 Pavia, Italy.

Gaetano De Ferrari (G)

Dipartimento di Scienze Mediche, Cardiologia Città della Salute e della Scienza, Università di Torino, 10126 Torino, Italy.

Antonio L Bartorelli (AL)

Centro Cardiologico Monzino IRCCS, 20138 Milan, Italy.
Department of Biomedical and Clinical Sciences "Luigi Sacco", University of Milan, 20157 Milan, Italy.

Giancarlo Marenzi (G)

Centro Cardiologico Monzino IRCCS, 20138 Milan, Italy.

Classifications MeSH